A Proof of Concept Study to Evaluate the Safety of Afamelanotide in Patients With Acute Arterial Ischaemic Stroke (AIS)
Clinical trial NCT04962503 · COMPLETED
Trial details
- NCT number
- NCT04962503
- Sponsor
- Clinuvel Pharmaceuticals Limited
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-03
- Primary completion
- 2022-02-04
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.